Prevalence of Anti- Hepatitis C Virus Antibodies among Patients Attending Sokoto Specialist Hospital, Sokoto State, Nigeria

Mustafa Alhaji Isa, U.K. Muhammad2, S.B. Manga, H.K. Mangga

Abstract


Hepatitis C virus is among the most common cause of viral hepatitis which considered as a major public health problem worldwide. This study was aimed to determine the prevalence of hepatitis C (HCV) antibody among patients attending Sokoto Specialist Hospital, using Acon ® Laboratory Inc, test kits, after the patients were advised on the need to know their status Of the 300 blood samples tested, 8 (2.7%) was positive for the presence of hepatitis C. Demographic variables (Occupation, Sex, Marital status and education) and risk factors (History of blood transfusion, history of sexual transmitted diseases, intravenous drug abuse and presence of tribal mark or tattoos) appeared not associated (p> 0.05) with the prevalence of HCV antibody. However, there is urgent need to take public health measures to reduce disease burden and transmission, by routine screening of all for HCV infections.


Keywords


HCV, prevalence, infection, risk factors

Full Text:

PDF

References


Ashraf, H., H.N. Alam, C. Rothermundr, A. Brooks, P. Bardhan, L. Hossain, A.M. Salam, S.M. Hassan, C. Beglinger and N. Gyr. 2010. Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh. BMC Infectious Diseases. 10:208. http://biomedcentral.com/1471-2334/10/208

Ayolabi, C.I., A.M. Taiwo, S.A. Omilabu, O.A. Abebisi and M.O Fatoba. 2006. Seroprevalence of Hepatitis C virus among Blood Donors in Lagos, Nigeria. African J. Biotechnol. 5(20): 1944-1946.

Bonkovsky, H.L., and S. Mehta. 2001. Hepatitis C. A review and updates. J. Am. Acad. Dermatol. 44:159-79.

Choudhary, I.A., S.A. Khan and A. Samiullah. 2005. Should we do hepatitis B and C screening on each patient before surgery. Pak J. Med. Sci. 21:278-80.

Cuschieri S.A., R.J.C. Steele and A. Moosa. 2002. R editors. Essential Surgical practice, 4th ed. London: Arnold.

Ebie, J.C. and O.A. Pela. 2006. Some sociocultural aspects of the problem of drug abuse in Nieria. Drug and Alc. Dep. 8: 301-306.

Ejele, O.A., C.A. Nwauche and O. Erhabor. 2006. Seroprevalence of Hepatitis C Virus in Niger Delta of Nigeria. The Nigerian Postgraduate Medical J. 13(2): 103- 106.

Frank, C., M. Mohammed, and G. Strickland. 2002. The role of parenteral antischistosomal therapy in the spread of Hepatitis C virus in Egypt. Lancet. 355: 887-891.

Frank, C., M.K. Mohamed, G.T. Strickland, D. Lavanchy, R.R. Arthur, L.S. Magder, T. El Khoby, Y. Abdel-Wahab, E.S. Aly Ohn, W. Anwar and I. Sallam. 2000. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 355:887-91.

Halim, N.K.D., and I.O. Ajayi. 2000. Risk factors and Seroprevalence of Hepatitis C antibody in Blood Donors in Nigeria. East African Medical J. 77(8): 410-412.

Hayashmi, J., Y. Kishiharar, K. Yamaji, E. Yoshimura, Y. Kawakami, K. Akazawa. 1995. Transmission of hepatitis C virus by Health care workers in a rural area of Japan. Am. Jm. Gastroenterol. 90(5):794-799.

Ikuomola, D.A. 2010. The socio-economic Implication of climatic change, desert encroachment and communal conflicts in northern Nigeria. Session: Climate change, conflict and livelihoods. Paper presented at the 250th Anniversary. Conference of the Royal Norwegian Society of Sciences and Letters on Climate Change and Security, Trondheim, Norway.

World Health Organization. 2000. Hepatitis B Fact sheet No 204. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/print.html.

Inyama, P.U., J. C. Uneke, I.G. Anyanwu, M.O. Njoku, J.H. Idokoand, A. J. Idoko. 2005. Prevalence of Antibodies to Hepatitis C virus among Nigerian patients with HIV infections. Online J. Health and Allied Sciences. 2:2. Available at www. Ojhas.org/issue14/2005-2-2.htm.

Khan, U.N., I. Ali, U.N. Ahmad, A. Iqbal, U.L. Rehman, I. Munir, U.M. Rehman, S. Khan, S. Ali, L. Siddique and A.Z. Swati. 2011. Prevalence of active HCV infection among the blood donors of Khyber Pakhtunkwa and FATA region of Pakistan and evaluation of the screening tests for anti-HCV. Virology Journal. 8:154. http://www.virologyj.com/content/8/1/154.

Memon, M.I., and M.A. Memon. 2002. Hepatitis C: an epidemiological review. J. Viral Hepat. 9:84-100.

Muhammad, S.K., J. Muhammad, J. Sakhi, Z. Shoaib, S. Shahid and S.S. Ahmed. 2007. Prevalence of hepatitis ‘B’ and ‘C’ in Orthopaedics patients at Ayub Teaching Hospital Abbottabad. J. Ayub Med. Coll Abbottabad. 19(4).

Mustapha, S.K., M.T. Bolori, N.A. Ajayi, H.A. Aggada, U.H. Pindiga, W. Gashau, M.I.A. Khalil. 2007. Hepatocellular carcinoma in north- Eastern Nigeria: A prospective Clinical Study of 100 cases. The Internet Journal of Gastroenterology. 6(1). https://ispub.com/IJGE/6/1/11995.

National Population Commission. 2006. Report of the final national census results. Abuja, Nigeria

Pennap, G.R., A. Yakubu, O. Oyige, J. Forbi. 2010. Prevalence of hepatitis B and C virus infection among people of a local community in Keffi, Nigeria. African Journal of Microbiology Research. 4 (4): 274-278.

Polyak, P. 2006. Innate intracellular defence against HIV and its modulation by HCV gene product. Postgraduate Course, Vienna, pp: 30-33.

Russel, R.C.G., N.S. Williams and C.J.K. Bulstrode. 2004. The liver. In: Bailey & Loves’ Short Practice of Surgery, 24th ed. London: Chapman & Hall. 1076p.

Schiff, E. 2002. Hepatitis Central, Current information on Hepatitis C and treatment for medical profession, Uni Miami, pp: 1–2.

Simonsen, L., A. Kane, J. Lloyd, M. Zaffran and M. Kane. 1999. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull. World Health Organ. 77: 789– 800.

Sokoto State Government of Nigeria. 2009. About Sokoto. Retrieved June 23, 2010.

Strickland, G.T. 2002. HCV in developing Countries. Postgrad. Doc. (Africa). 24: 18-20.

Sule W.F., L.E. Odama, A.L. Daniel, A.O. Faneye and I.O. Okonko. 2009. Prevalence of Anti- Hepatitis C Virus in patients attending Federal Medical Centre (FMC), Lokoja, Kogi State, Nigeria. World Applied Sciences Journal. 7(3): 371- 377.

Tess, B.H., A. Levin, G. Brubaker, J. Shao, E. J. Drummond, J.H. Alter, and O.R.T. Brien. 2000. Seroprevalence of Hepatitis C Virus in the General population of Northwest Tanzania. American J. Tropical Medicine and Hygiene. 62(1): 138- 141.

Ugbebor, O., M. Aigbirior, F. Osazuwa, E. Ehigha and O. Zabayo. 2011. The prevalence of hepatitis B and C viral infections among pregnant women. North American Journal of Medical Sciences. 3(5): 238-241.

Wang, S.C., T.T. Chang, J.W. Yao and P. Chou. 2002. Comparison of Hepatitis B virus and Hepatitis C virus prevalence and risk factors in a community-based study. Am. J. Trop. Med. Hyg. 66(4): 389–393.

World Health Organisation. 2007. Hepatitis C, estimated prevalence and number infected by world region. Available at http://www.who.int/csr/disease/hepatitis.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2014 The Journal of Applied Sciences Research

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.